Status:
WITHDRAWN
Study of Blood Platelets in Sickle Cell Disease
Lead Sponsor:
Rockefeller University
Collaborating Sponsors:
Icahn School of Medicine at Mount Sinai
Schneider Children's Hospital of North Shore
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
7+ years
Brief Summary
We are studying if sickle cell disease blood platelets are larger than normal and how they may cause obstruction of blood vessels. We are also trying to study the reasons why large platelets are found...
Detailed Description
Research volunteers are seen in the Outpatient Research Center by the Principal Investigator or another physician. A detailed history is obtained, a physical examination is performed, and blood (usual...
Eligibility Criteria
Inclusion
- Adults and children \> 7 years of age with sickle cell disease (Hb SS) who are not taking hydroxyurea and are not receiving routine blood transfusion therapy.
Exclusion
- Current hydroxyurea therapy or,
- Hydroxyurea use within the past 3 months
- Blood transfusion or exchange transfusion within the past 3 months
- Current treatment with aspirin or clopidogrel
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00226083
Start Date
August 1 2005
End Date
September 1 2007
Last Update
June 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rockefeller University Hospital
New York, New York, United States, 10021